Silexion Therapeutics SLXN
NASDAQ SLXN
$0.17 +0.01 (+7.74%)
As of: Oct 21, 2026 · 12:46 PM EDT

Silexion Therapeutics (SLXN) Debt Ratio (2024 - 2025)

Updated

Silexion Therapeutics' (SLXN) Debt Ratio stood at 0.22 in Q4 2025, down 79.0% from 1.03 a year earlier but up 63.9% from the prior quarter.

Analysis

Silexion Therapeutics (SLXN) Debt Ratio (2024 - 2025) Analysis & Trends

Starting with Q3 2024, Silexion Therapeutics' Debt Ratio history includes 6 quarters.

  • Across earlier years, Debt Ratio came in at 1.03 in FY2024.
  • Quarterly Debt Ratio has ranged from 0.13 in Q3 2025 to 1.03 in Q4 2024 over the past five years.
  • Per Business Quant, the preceding three quarters came in at 0.13 (Q3 2025), 0.55 (Q2 2025) and 0.36 (Q1 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Eli Lilly 1,132.21 Bn 1,100.80 Bn 19.71 Bn 0.39
2 Johnson & Johnson 616.27 Bn 534.80 Bn 17.26 Bn 0.24
3 AbbVie 500.10 Bn 473.21 Bn 12.70 Bn 0.52
4 Merck 366.86 Bn 321.23 Bn 12.21 Bn 0.42
5 Novartis Ag 297.92 Bn 261.91 Bn 11.24 Bn 0.08
6 Astrazeneca 261.53 Bn 235.22 Bn 12.86 Bn 0.28
7 Amgen 234.99 Bn 190.39 Bn 7.24 Bn 0.60
8 Gilead Sciences 190.14 Bn 164.34 Bn 6.22 Bn 0.53
9 Pfizer 169.63 Bn 116.28 Bn 10.94 Bn 0.31
10 Silexion Therapeutics 113,894.39 -19.76 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 0.22
Sep 30, 2025 0.13
Jun 30, 2025 0.55
Mar 31, 2025 0.36
Dec 31, 2024 1.03
Sep 30, 2024 1.01
API Access

Silexion Therapeutics Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=SLXN&period=max&api_key=YOUR_API_KEY